Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population
NCT02302573Completed
- Sponsor
- University Hospital Tours
- Start
- May 2009
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sulfur hexafluoride in placenta accreta (PAS), sponsored by University Hospital Tours. Primary endpoint: Conventional contrast enhanced ultrasound parameters for diagnosing placenta accreta at 9 months. Started May 2009; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
placenta accreta (PAS)
Beyond the preview
Go deeper on NCT02302573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02302573.